Moolec Science (MLEC) Common Equity (2022 - 2026)

Moolec Science has disclosed Common Equity across 5 years of filings, most recently posting $11.3 million for Q1 2026.

• Common Equity for Q1 2026 came in at $11.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $11.3 million (changed N/A YoY), and the FY2025 annual result was -$84.5 million, down 7071.03% from the prior year.
• Common Equity came in at $11.3 million for Q1 2026 at Moolec Science, down from $15.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $258.6 million in Q2 2023 to a low of -$84.5 million in Q2 2025.
• The 5-year median for Common Equity is $6.7 million (2023), against an average of $28.6 million.
• Peak annual rise in Common Equity reached 442.79% in 2025, while the deepest fall reached 7071.03% in 2025.
• Moolec Science's Common Equity stood at $11.9 million in 2022, then slumped by 43.82% to $6.7 million in 2023, then sank by 58.16% to $2.8 million in 2024, then jumped by 442.79% to $15.2 million in 2025, then slipped by 25.56% to $11.3 million in 2026.
• The last three Common Equity figures came in at $11.3 million (Q1 2026), $15.2 million (Q4 2025), and -$84.5 million (Q2 2025), per Business Quant data.